Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985 Jan 1;161(1):40-52.
doi: 10.1084/jem.161.1.40.

Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo

Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo

J F Bukowski et al. J Exp Med. .

Abstract

We carried out adoptive transfer studies to determine the role of natural killer (NK) cells in resistance to murine cytomegalovirus (MCMV) and lymphocytic choriomeningitis virus (LCMV). We transferred leukocytes from adult mice into suckling mice 1 d before injecting them with virus. Resistance was measured by enhancement of survival and reduction of virus multiplication in the spleens of recipient mice. The phenotype of the cell population capable of mediating resistance to MCMV was that of a nylon wool-nonadherent, asialo GM1+, NK 1.2+, Ly-5+, Thy-1-, Ia-, low density lymphocyte; this is the phenotype of an NK cell. Cloned NK cells, but not cloned T cells, provided resistance to MCMV in suckling mice. Cloned NK cells also provided resistance to MCMV in irradiated adult mice, and antibody to asialo GM1, which depletes NK cell activity in vivo, enhanced the synthesis of MCMV in athymic nude mice. Neither adult leukocytes nor cloned NK cells influenced LCMV synthesis in suckling mice. We conclude that a general property of NK cells may be to provide natural resistance to virus infections, and that NK cells can protect mice from MCMV but not from LCMV.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Infect Immun. 1978 Sep;21(3):840-2 - PubMed
    1. J Virol. 1984 Jul;51(1):117-22 - PubMed
    1. J Exp Med. 1979 Jan 1;149(1):273-8 - PubMed
    1. J Exp Med. 1979 May 1;149(5):1117-33 - PubMed
    1. J Immunol. 1980 Jan;124(1):418-23 - PubMed

Publication types

MeSH terms